CA2067200A1 - Synthese totale d'enantiomeres de la northebaine, normorphine, noroxymorphone et de leurs derives par des intermediaires n-nor - Google Patents

Synthese totale d'enantiomeres de la northebaine, normorphine, noroxymorphone et de leurs derives par des intermediaires n-nor

Info

Publication number
CA2067200A1
CA2067200A1 CA2067200A CA2067200A CA2067200A1 CA 2067200 A1 CA2067200 A1 CA 2067200A1 CA 2067200 A CA2067200 A CA 2067200A CA 2067200 A CA2067200 A CA 2067200A CA 2067200 A1 CA2067200 A1 CA 2067200A1
Authority
CA
Canada
Prior art keywords
ether
intermediates
northebaine
noroxymorphone
normorphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2067200A
Other languages
English (en)
Other versions
CA2067200C (fr
Inventor
Kenner C. Rice
Amy H. Newman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2067200A1 publication Critical patent/CA2067200A1/fr
Application granted granted Critical
Publication of CA2067200C publication Critical patent/CA2067200C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Des familles d'antagonistes-agonistes et de stupéfiants opiacés sont préparées à partir de la norhydrocodéinone. Dans une concrétisation préférée de l'invention, la norhydrocodéinone est chauffée au reflux avec le diméthylcétal sulfosalicylique et des dérivés éther du delta-6-énol, puis est convertie entièrement en éther par l'addition de tétrahydrofurane anhydre en même temps que l'élimination de l'éther ainsi produit. Ensuite, on fait réagir l'éther avec de l'acide méthanesulfonique et du N-bromoacétamide pour obtenir le bromhydrate du dérivé 7-bromodiméthylcétal. On peut obtenir, à partir de ce dérivé, divers produits dont le nouvel intermédiaire plus poussé 14-hydroxynorcodéinone. La présente invention permet d'obtenir des dérivés à partir d'un produit de départ qui, contrairement aux produits de départ des procédés antérieurs, est disponible sous forme naturelle (-) ou synthétique (+). Ainsi, la méthode décrite dans la présente invention est la seule connue qui permette de synthétiser les formes (+) des divers dérivés et intermédiaires, comme la (+)-7-bromo-diméthylcétal-nordihydrocodéinone.
CA002067200A 1989-10-16 1990-10-16 Synthese totale d'enantiomeres de la northebaine, normorphine, noroxymorphone et de leurs derives par des intermediaires n-nor Expired - Lifetime CA2067200C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42190089A 1989-10-16 1989-10-16
US421,900 1989-10-16

Publications (2)

Publication Number Publication Date
CA2067200A1 true CA2067200A1 (fr) 1991-04-17
CA2067200C CA2067200C (fr) 1998-06-30

Family

ID=23672545

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002067200A Expired - Lifetime CA2067200C (fr) 1989-10-16 1990-10-16 Synthese totale d'enantiomeres de la northebaine, normorphine, noroxymorphone et de leurs derives par des intermediaires n-nor

Country Status (10)

Country Link
EP (1) EP0496830B1 (fr)
JP (1) JP2694156B2 (fr)
AT (1) ATE178329T1 (fr)
AU (1) AU642447B2 (fr)
CA (1) CA2067200C (fr)
DE (1) DE69033035T2 (fr)
DK (1) DK0496830T3 (fr)
ES (1) ES2129395T3 (fr)
GR (1) GR3030101T3 (fr)
WO (1) WO1991005768A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006084389A1 (fr) * 2005-02-11 2006-08-17 Cilag Ltd. Procede pour epurer des composes de noroxymorphone
ES2357216T3 (es) * 2005-06-16 2011-04-20 Mallinckrodt, Inc. Una ruta de síntesis de 14-hidroxil-opiáceos a través de 1-halo-tebaína o análogos.
US20100210675A1 (en) * 2007-04-27 2010-08-19 Cilag Ag Solvent-free crystalline form of naltrexone
WO2009067275A1 (fr) * 2007-11-21 2009-05-28 Progenics Pharmaceuticals, Inc N-oxydes d'analogues 4,5-époxy-morphinanium
AU2008338970B2 (en) * 2007-12-17 2013-08-22 SpecGx LLC Sinomenine derivatives and processes for their synthesis
AU2008338969B2 (en) * 2007-12-17 2013-08-01 SpecGx LLC Process and compounds for the production of (+) opiates
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
RS55777B1 (sr) 2010-11-05 2017-07-31 H Lundbeck As Postupak za proizvodnju naltreksona
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
AU2012253188B2 (en) * 2011-05-06 2016-12-22 Brock University Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer
US20140155608A1 (en) 2012-05-03 2014-06-05 H. Lundbeck A/S Method for the manufacturing of naltrexone
ES2631197T3 (es) 2012-12-14 2017-08-29 Purdue Pharma Lp Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes
US9340542B2 (en) 2013-12-26 2016-05-17 Purdue Pharma L.P. Propellane-based compounds and the use thereof
WO2015192039A1 (fr) * 2014-06-13 2015-12-17 Purdue Pharma L.P. Dérivés hétérocycliques de morphinan et leur utilisation
WO2022076470A1 (fr) 2020-10-06 2022-04-14 Sorrento Therapeutics, Inc. Formulation orale à libération rapide retardée de naltrexone ou de naloxone à faible dose utilisée pour traiter la fibromyalgie et le covid long
CN120703275B (zh) * 2025-08-27 2025-11-25 上海万巷制药有限公司 一种罂粟油中可待因、吗啡、罂粟碱、那可丁和蒂巴因含量的测定方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA913077A (en) * 1972-10-24 J. Pachter Irwin Process of preparing n-substituted 14-hydroxydihydronormorphines
BE638369A (fr) * 1962-10-10
FR2208902A1 (en) * 1972-06-15 1974-06-28 Merck & Co Inc 14-Hydroxy dihydronormorphinone prepn. - from 1-halo-nor codeinone, by oxidn., catalytic redn. and hydrolysis
US4141897A (en) * 1976-12-20 1979-02-27 Research Corporation N-dealkylation of N-alkyl-14-hydroxymorphinans and derivatives thereof
NO793297L (no) * 1978-10-19 1980-04-22 Mallinckrodt Inc Fremgangsmaate til fremstilling av oksymorfon
NO802139L (no) * 1979-08-09 1981-02-10 Mallinckrodt Inc Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
US4368326A (en) * 1980-07-03 1983-01-11 Rice Kenner C Short total synthesis of dihydrothebainone, dihydrocodeinone, and nordihydroccodeinone
US4521601A (en) * 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4472253A (en) * 1981-08-17 1984-09-18 The Florida Board Of Regents On Behalf Of The Florida State University Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative
US4613668A (en) * 1983-12-22 1986-09-23 The United States Of America As Represented By The Department Of Health And Human Services Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
US4639520A (en) * 1984-03-27 1987-01-27 Mallinckrodt, Inc. Preparation of 14-hydroxy-N-ethoxy-carbonyl-norcodeinone
JPS62123444A (ja) * 1985-08-07 1987-06-04 Japan Synthetic Rubber Co Ltd ポジ型感放射線性樹脂組成物
JPH0721626B2 (ja) * 1985-08-10 1995-03-08 日本合成ゴム株式会社 半導体微細加工用レジスト組成物

Also Published As

Publication number Publication date
EP0496830A4 (en) 1992-09-30
EP0496830A1 (fr) 1992-08-05
DE69033035T2 (de) 1999-08-05
EP0496830B1 (fr) 1999-03-31
CA2067200C (fr) 1998-06-30
DK0496830T3 (da) 1999-10-11
ES2129395T3 (es) 1999-06-16
AU642447B2 (en) 1993-10-21
JP2694156B2 (ja) 1997-12-24
WO1991005768A1 (fr) 1991-05-02
DE69033035D1 (de) 1999-05-06
JPH04504861A (ja) 1992-08-27
ATE178329T1 (de) 1999-04-15
AU6742690A (en) 1991-05-16
GR3030101T3 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
CA2067200A1 (fr) Synthese totale d'enantiomeres de la northebaine, normorphine, noroxymorphone et de leurs derives par des intermediaires n-nor
DE69107622D1 (de) Verfahren zur herstellung von (4r-cis)-1,1-dimethylethyl-6-cyanmethyl-2,2-dimethyl-1,3-dioxan-4-acetat.
EP0635019A4 (fr)
ATE136899T1 (de) Verfahren zur herstellung eines n- phenylacetylderivats von tetrahydrothieno(3,2- c>pyridin und zwischenprodukt der synthese
ATE402937T1 (de) Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
DE3588095D1 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
HUT68166A (en) Process for preparing substituted piperidines
DE69920676D1 (de) Verfahren zur Herstellung von Amin-Umsetzungsprodukt-Teilchen
DE69307758D1 (de) Integriertes Verfahren zum Herstellen von acetylierten Sauerstoffverbindungen aus Synthesegas über Dimethyläther
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
EP0343454A3 (fr) Procédé de préparation de l'éther diméthylique
ATE305000T1 (de) Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind
PT79837B (en) Process for the preparation of 5,11-dihydro-6h-dibenzo<b,e>azepine-6-ones substituted and pharmaceutical compositions therewith
DE69023562D1 (de) Verfahren zur Herstellung von Feinmustern.
ATE114637T1 (de) Verfahren zur herstellung von antikonvulsanten cyclischen aminosäureverbindungen.
DE69023532D1 (de) Verfahren zur Synthese von Acylamino-Organosilicium-Verbindungen.
DE69014152D1 (de) Verfahren zur Herstellung von Tigogenin-beta-Cellobioside.
ATE96464T1 (de) Verfahren zur herstellung von thiolen.
DE69011719D1 (de) Verfahren zur Synthese von Acylamino-organosilicium-Verbindungen.
DE3161243D1 (en) 22-arylsulfonyl-24,25-dihydroxycholestanes and process for preparing the same
DE69006888D1 (de) Verfahren zur Synthese von Acylamino-Organosilicon-Verbindungen.
ATE111458T1 (de) Verfahren zur darstellung von hochreinem tetrahydrofuran.
ATE159021T1 (de) Verfahren zur herstellung von penem derivaten und zwischenprodukte zu dieser herstellung
DE60039533D1 (de) Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
ATE131155T1 (de) Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2- hydroxymethyl-3,4,5-trihydroxypiperidine.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202